Lim Bryant David 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jan 10, 2023
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Award
Common Stock
2023-01-06+399,218→ 429,652 total - Tax Payment
Common Stock
2023-01-06$0.71/sh−119,957$85,157→ 309,695 total
Footnotes (2)
- [F1]Represents shares of common stock granted under the Idera Pharmaceuticals, Inc. 2013 Stock Incentive Plan, as amended and restated. The shares were granted pursuant to that certain Employment Continuation and Retention Bonus Letter Agreement, dated as of September 28, 2022, between the Issuer and Reporting Person.
- [F2]Represents the number of shares withheld by Issuer to cover tax obligations in connection with the grant of the shares of common stock.